We are live on ! Find out more
SM

SG3 Management Portfolio holdings

AUM $6.45K
1-Year Est. Return 61.81%
This Fund
S&P 500
This Quarter Est. Return
+6.6%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
AUM
$3.3B
AUM Growth
+$481M
Cap. Flow
+$512M
Cap. Flow %
15.52%
Top 10 Hldgs %
30.72%
Holding
1,380
New
403
Increased
148
Reduced
188
Closed
428

Sector Composition

Rank Sector Weight
1 Healthcare 3.28%
2 Communication Services 1.55%
3 Technology 0.91%
4 Consumer Discretionary 0.74%
5 Financials 0.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRK icon
1151
Merck
MRK
$322B
-15,000
Closed -$1.14M
MSOS icon
1152
AdvisorShares Pure US Cannabis ETF
MSOS
$814M
-51,532
Closed -$1.79M
MU icon
1153
Micron Technology
MU
$835B
-3,500
Closed -$297K
NBIX icon
1154
CALL
Neurocrine Biosciences
NBIX
$18.2B
-20,000
Closed -$1.95M
NBIX icon
1155
Neurocrine Biosciences
NBIX
$18.2B
-8,500
Closed -$827K
NBIX icon
1156
PUT
Neurocrine Biosciences
NBIX
$18.2B
-27,000
Closed -$2.63M
NET icon
1157
CALL
Cloudflare
NET
$96B
-120,000
Closed -$12.7M
NKE icon
1158
PUT
Nike
NKE
$64.1B
-10,000
Closed -$1.54M
NNBR icon
1159
CALL
NN Inc
NNBR
$237M
-36,700
Closed -$270K
NNOX icon
1160
CALL
Nano X Imaging
NNOX
$61.1M
-11,000
Closed -$353K
NNOX icon
1161
PUT
Nano X Imaging
NNOX
$61.1M
-7,500
Closed -$240K
NVAX icon
1162
Novavax
NVAX
$1.21B
-2,000
Closed -$425K
NVCR icon
1163
CALL
NovoCure
NVCR
$1.76B
-30,000
Closed -$6.66M
OGN icon
1164
Organon & Co
OGN
$3.56B
-500
Closed -$15K
OMCL icon
1165
CALL
Omnicell
OMCL
$1.88B
-15,000
Closed -$2.27M
OMCL icon
1166
Omnicell
OMCL
$1.88B
-15,000
Closed -$2.27M
OMCL icon
1167
PUT
Omnicell
OMCL
$1.88B
-85,000
Closed -$12.9M
OMER icon
1168
Omeros
OMER
$845M
-70,500
Closed -$1.06M
OPEN icon
1169
CALL
Opendoor
OPEN
$3.54B
-140,533
Closed -$2.41M
OSW icon
1170
CALL
OneSpaWorld
OSW
$2.64B
-25,000
Closed -$242K
OWL icon
1171
CALL
Blue Owl Capital
OWL
$6.45B
-81,400
Closed -$1.05M
OVV icon
1172
CALL
Ovintiv
OVV
$17B
-50,000
Closed -$1.57M
PACB icon
1173
Pacific Biosciences
PACB
$435M
-10,000
Closed -$350K
PACB icon
1174
PUT
Pacific Biosciences
PACB
$435M
-10,000
Closed -$350K
PAGP icon
1175
Plains GP Holdings
PAGP
$5.28B
-3,500
Closed -$36.6K

Similar funds

SG3 Management's Q3 2021 Portfolio in Review

As of Q3 2021, SG3 Management held 1,380 positions worth $3.3B, up 17% from $2.82B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

SG3 Management deployed $512M of net new capital in Q3 2021, opening 403 new positions and adding to 148 existing holdings. Its largest new stake was Alphabet (Google) Class C: 300,000 shares worth $40M.

By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.3% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was Bank of America, an estimated $4.85M trimmed.

  • SG3 Management's largest Q3 2021 buy was Alphabet (Google) Class C: 300,000 shares worth $40M.
  • SG3 Management added most to Bausch Health in Q3 2021, an estimated $7.4M increase.
  • SG3 Management's biggest Q3 2021 reduction was Bank of America, cutting an estimated $4.85M.
  • SG3 Management fully exited Alphabet (Google) Class A in Q3 2021, selling an estimated $24.4M.
  • SG3 Management's ten largest holdings make up 31% of its $3.3B portfolio in Q3 2021.
  • SG3 Management opened 403 new positions and closed 428 in Q3 2021.
  • SG3 Management's portfolio value rose 17% quarter-over-quarter to $3.3B.

Based on SG3 Management's 13F filing for Q3 2021, filed 15 Nov 2021.